Page results
-
The highly specialist service for McArdle Disease and related disorders was established in 2011 at the National Hospital for Neurology and Neurosurgery (NHNN) to offer high-quality care to patients…
-
This page will give you an overview of intravesical chemotherapy, how it is given and side effects it may cause.
-
When you are looking for nursing jobs in London, we know there are unlimited options out there for you to choose from. As a multi-disciplinary specialist hospital group, UCLH is a great place to start, with opportunities in a wide range of nursing roles from paediatric nursing to emergency nursing to oncology nursing. The National Hospital for Neurology and Neurosurgery also provides opportunities for specialist neuroscience nursing. At UCLH, we have a real ‘One Team’ ethos, and our values – safety, kindness, teamwork and improving – are central to the way we work. We are a diverse and inclusive employer, with a culture that creates a real sense of belonging and trust, filled with people who are representative of our local communities. That’s we our staff have voted us the best NHS Trust to work for in England two years running. Why not have a look at our vacancies and find your next nursing role? UCLH. It starts with you.
-
This information explains when planned caesareans would be provided at The Whittington Hospital for women having antenatal care at UCLH.
-
Patient information on managing pain
-
This page provides information about ERCP (Endoscopic Retrograde Cholangiopancreatography) procedure.
-
UCLH vision, values and strategy
-
This page explains what an intra-oral scanner is and what it is used for.
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
-
Health and wellbeing information for people affected by cancer.
File results
-
FOI/2022/0209 - Patient tracking list or waiting lists
-
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
-
FOI/2022/0212 - Clotting disorders medication
-
FOI/2022/0214 - Prostate Cancer (Summary Funding and costs of Xtandi (Enzalutamide) trial: NCT00974311) Xtandi (Enzalutamide) trial, NCT00974311
-
FOI/2022/0217 - Medications for dermatological conditions
-
FOI/2022/0221 - Asthma medications
-
FOI/2022/0223 - Policies/ procedures for management of patients with chest pain
-
FOI/2022/0224 - Procurement for physiotherapy, occupational therapy, pharmacy, radiography, speech and language therapy and sterile services
-
FOI/2022/0226 - Treatments for Haemophilia A
-
FOI/2022/0227 - Number of cancer trackers and cancer MDT co-ordinators at Trust